Nick Daneman

15.6k total citations · 6 hit papers
271 papers, 8.4k citations indexed

About

Nick Daneman is a scholar working on Applied Microbiology and Biotechnology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Nick Daneman has authored 271 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Applied Microbiology and Biotechnology, 107 papers in Epidemiology and 72 papers in Infectious Diseases. Recurrent topics in Nick Daneman's work include Antibiotic Use and Resistance (112 papers), Bacterial Identification and Susceptibility Testing (60 papers) and Patient Satisfaction in Healthcare (47 papers). Nick Daneman is often cited by papers focused on Antibiotic Use and Resistance (112 papers), Bacterial Identification and Susceptibility Testing (60 papers) and Patient Satisfaction in Healthcare (47 papers). Nick Daneman collaborates with scholars based in Canada, United States and Australia. Nick Daneman's co-authors include Kevin A. Brown, Bradley J. Langford, Derek R. MacFadden, Valerie Leung, Miranda So, Sumit Raybardhan, Duncan Westwood, Marion Elligsen, David N. Fisman and Andrew E. Simor and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Nick Daneman

252 papers receiving 8.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

2020 999 citations Bradley J. Langford, Miranda So et al. Clinical Microbiology and Infection profile →
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis

2021 525 citations Bradley J. Langford, Miranda So et al. Clinical Microbiology and Infection profile →
Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile Infection

2013 419 citations Kevin A. Brown, Nick Daneman et al. Antimicrobial Agents and Chemotherapy profile →
Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada

2022 180 citations Sarah A. Buchan, Nick Daneman et al. profile →
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis

2022 131 citations Bradley J. Langford, Jean‐Paul Soucy et al. Clinical Microbiology and Infection profile →
Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis

2023 91 citations Bradley J. Langford, Miranda So et al. The Lancet Microbe profile →

Peers

Countries citing papers authored by Nick Daneman

Since Specialization

Citations

This map shows the geographic impact of Nick Daneman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Daneman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Daneman more than expected).

Fields of papers citing papers by Nick Daneman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Daneman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Daneman. The network helps show where Nick Daneman may publish in the future.

Co-authorship network of co-authors of Nick Daneman

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Daneman. A scholar is included among the top collaborators of Nick Daneman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Daneman. Nick Daneman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trial 2025 ·The Lancet Infectious Diseases ·Sean Wei Xiang Ong, Ruxandra Pinto, Robert K. Mahar, Asgar Rishu, Joshua S. Davis, Robert Fowler, Steven Y. C. Tong, Nick Daneman, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
2	Resourcing for hospital antibiotic stewardship programs is associated with higher participation in antimicrobial use tracking: a cross-sectional study 2025 ·Antimicrobial Stewardship & Healthcare Epidemiology ·Bradley J. Langford, (unknown), Kevin A. Brown, Nick Daneman, Kevin L. Schwartz, Valerie Leung	1
3	Reporting of socio-demographic characteristics of trial participants in infectious diseases clinical trials – a systematic review 2025 ·medRxiv ·Sean Wei Xiang Ong, (unknown), (unknown), (unknown), Matthew James Slater, (unknown), (unknown), (unknown), (unknown), Esmita Charani, Nick Daneman, Steven Y. C. Tong	0
4	Making Sense of Hierarchical Composite End Points in Randomized Clinical Trials—A Primer for Infectious Diseases Clinicians and Researchers 2025 ·Clinical Infectious Diseases ·Sean Wei Xiang Ong, Robert K. Mahar, (unknown), Ruxandra Pinto, (unknown), Robert Fowler, Steven Y. C. Tong, Nick Daneman	1
5	Incidence of Respiratory Syncytial Virus-Associated Hospitalization Among Adults in Ontario, Canada, 2017–2019 2025 ·The Journal of Infectious Diseases ·Sarah A. Buchan, (unknown), Samantha S. M. Drover, Melissa K. Andrew, Susan E. Bronskill, Kevin A. Brown, Nick Daneman, Shelley L. Deeks, Jonathan B. Gubbay, Jennie Johnstone, Timothy Karnauchow, Samantha Lee, (unknown), James Dayre McNally, Shelly McNeil, Samira Mubareka, Michelle Murti, Marek Smieja, (unknown), Jeffrey C. Kwong	0
6	Follow-up blood cultures do not reduce mortality in hospitalized patients with Gram-negative bloodstream infection: a retrospective population-wide cohort study 2024 ·Clinical Microbiology and Infection ·Sean Wei Xiang Ong, Jin Luo, Daniel J. Fridman, Samantha Lee, Jennie Johnstone, Kevin L. Schwartz, Christina Diong, Samir N. Patel, Derek R. MacFadden, Bradley J. Langford, Steven Y. C. Tong, Kevin A. Brown, Nick Daneman	4
7	Long-term Risk of Infection Among Patients Colonized With Antimicrobial-Resistant Pathogens: A Population-wide Cohort Study 2024 ·Open Forum Infectious Diseases ·(unknown), Kevin A. Brown, Christina Diong, Daniel J. Fridman, Jennie Johnstone, Bradley J. Langford, Samantha Lee, Derek R. MacFadden, Kevin L. Schwartz, Nick Daneman	3
8	Epidemiology and clinical relevance of persistent bacteraemia in patients with Gram-negative bloodstream infection: a retrospective cohort study 2024 ·Journal of Antimicrobial Chemotherapy ·Sean Wei Xiang Ong, Jin Luo, Daniel J. Fridman, Samantha Lee, Jennie Johnstone, Kevin L. Schwartz, Christina Diong, Samir N. Patel, Derek R. MacFadden, Bradley J. Langford, Steven Y. C. Tong, Kevin A. Brown, Nick Daneman	3
9	Evaluating the impact of a SIMPlified LaYered consent process on recruitment of potential participants to the Staphylococcus aureus Network Adaptive Platform trial: study protocol for a multicentre pragmatic nested randomised clinical trial (SIMPLY-SNAP trial) 2024 ·BMJ Open ·Sean Wei Xiang Ong, Todd C. Lee, Robert Fowler, Robert K. Mahar, Ruxandra Pinto, (unknown), (unknown), (unknown), Matthew P. Cheng, Emily G. McDonald, Jennie Johnstone, Dominik Mertz, Christopher Kandel, Ranjani Somayaji, Joshua S. Davis, Steven Y. C. Tong, Nick Daneman	1
10	Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis breakdown → 2023 ·The Lancet Microbe ·Bradley J. Langford, Miranda So, (unknown), Valerie Leung, Jennifer Lo, (unknown), Sumit Raybardhan, (unknown), (unknown), Ashley Farrell, Elizabeth Leung, Jean‐Paul Soucy, Alessandro Cassini, Derek R. MacFadden, Nick Daneman, Silvia Bertagnolio	91
11	Factors associated with lung function response with oral antibiotic treatment of pulmonary exacerbations in cystic fibrosis 2023 ·Journal of Cystic Fibrosis ·Ana C. Blanchard, Michelle Shaw, Félix Ratjen, Elizabeth Tullis, Nick Daneman, Valerie Waters	4
12	Patient predictors of pathogenic versus commensal Gram-positive bacilli organisms isolated from blood cultures 2023 ·SHILAP Revista de lepidopterología ·(unknown), Marion Elligsen, Nick Daneman, Philip W. Lam	1
13	Evaluating the impact of a virtual outpatient care programme in preventing hospitalizations, emergency department visits and mortality for patients with COVID-19: a matched cohort study 2023 ·Clinical Microbiology and Infection ·(unknown), Philip W. Lam, Adrienne K. Chan, Nisha Andany, Andrew E. Simor, (unknown), (unknown), (unknown), (unknown), Daniel Fridman, Samantha Lee, (unknown), (unknown), Nick Daneman	3
14	A Time Series Analysis Evaluating Antibiotic Prescription Rates in Long-Term Care during the COVID-19 Pandemic in Alberta and Ontario, Canada 2022 ·Antibiotics ·Manon Haverkate, Derek R. MacFadden, Nick Daneman, Jenine Leal, Michael Otterstatter, (unknown), (unknown), Elissa Rennert‐May, Michael H. Silverman, Kevin L. Schwartz, Andrew M. Morris, (unknown), David M. Patrick, Fawziah Marra	2
15	Characteristics Associated With Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Ontario, Canada: A Cohort Study 2021 ·Clinical Infectious Diseases ·Lauren A. Paul, Nick Daneman, Kevin A. Brown, James Johnson, (unknown), (unknown), Sarah E. Wilson, Sarah A. Buchan	17
16	Increased Household Secondary Attacks Rates With Variant of Concern Severe Acute Respiratory Syndrome Coronavirus 2 Index Cases 2021 ·Clinical Infectious Diseases ·Sarah A. Buchan, (unknown), Nick Daneman, Michael Whelan, Thuva Vanniyasingam, Michelle Murti, Kevin A. Brown	17
17	Initial antimicrobial management of sepsis 2021 ·Critical Care ·Michael S. Niederman, Rebecca M. Baron, Lila Bouadma, Thierry Calandra, Nick Daneman, Jan J. De Waele, Marin H. Kollef, Jeffrey Lipman, Girish B. Nair	106
18	Antibiotic Prescribing Choices and Their Comparative C. Difficile Infection Risks: A Longitudinal Case-Cohort Study 2020 ·Clinical Infectious Diseases ·Kevin A. Brown, Bradley J. Langford, Kevin L. Schwartz, Christina Diong, Gary Garber, Nick Daneman	60
19	Using Genetic Distance from Archived Samples for the Prediction of Antibiotic Resistance in Escherichia coli 2020 ·Antimicrobial Agents and Chemotherapy ·Derek R. MacFadden, Bryan Coburn, Karel Břinda, (unknown), Nick Daneman, David N. Fisman, (unknown), Marc Lipsitch, Allison McGeer, Roberto G. Melano, Samira Mubareka, William P. Hanage	8
20	The Association Between High and Unnecessary Antibiotic Prescribing: A Cohort Study Using Family Physician Electronic Medical Records 2020 ·Clinical Infectious Diseases ·Taito Kitano, Bradley J. Langford, Kevin A. Brown, Andrea Pang, Branson Chen, Gary Garber, Nick Daneman, Karen Tu, Valerie Leung, Elisa Candido, (unknown), Jeremiah Hwee, Michael E. Silverman, Kevin L. Schwartz	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact